By Messrs. O'Day of West Boylston and Brodeur of Melrose, a petition (accompanied by bill, House, No. 2053) of James J. O'Day, Paul Brodeur and others relative to sexual education programs in certain public schools. Education.
By Mr. DiDomenico, a petition (accompanied by bill, Senate, No. 234) of Sal N. DiDomenico, Solomon Goldstein-Rose, Jack Lewis, Steven Ultrino and other members of the General Court for legislation relative to student sex education. Education.
By Ms. Creem, a petition (accompanied by bill, Senate, No. 1504) of Cynthia S. Creem, Angelo L. D'Emilia, Jason M. Lewis, Paul A. Schmid, III and other members of the General Court for legislation to sustain community preservation revenue. Revenue.
By Messrs. Kulik of Worthington and Honan of Boston, a petition (accompanied by bill, House, No. 2615) of Stephen Kulik and others for legislation to further regulate expenditures for mortgages from the Community Preservation Trust Fund. Revenue.
By Ms. Lovely, a petition (accompanied by bill, Senate, No. 1023) of Joan B. Lovely, Michelle M. DuBois, Eric P. Lesser, Jack Lewis and other members of the General Court for legislation to establish the Massachusetts pregnant workers fairness act. Labor and Workforce Development.
By Mr. Rogers of Cambridge, a petition (accompanied by bill, House, No. 1038) of David M. Rogers and others relative to protecting pregnant workers from discrimination in the workplace. Labor and Workforce Development.
Maddy summaryThis bill regulates pharmacy benefit managers (PBMs) to improve transparency and fairness in drug pricing. It requires PBMs to: (1) pay pharmacies promptly for "clean claims" (complete, error-free claims) without retroactively reducing payments; (2) cap patient cost-sharing (copays, deductibles) at the pharmacy’s contracted price; and (3) maintain transparent, frequently updated maximum allowable cost lists for generic drugs, allowing pharmacies to challenge unfair pricing. The bill directly affects PBMs, community pharmacies (excluding mail-order from network calculations), and patients who pay for prescriptions. Key provisions aim to prevent unexpected payment cuts and ensure fair reimbursement based on actual drug costs.
